SEC-sourced researchBeta
CDIX
Cardiff Lexington Corp
Company comparison ↗
Data passport
- CIK
- 0000811222
- Exchange
- OTC
- Business activity
- Services-Offices & Clinics of Doctors of Medicine · SIC 8011
- Financial inputs
- 6/6
- Filing date
- Nov 10, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 8,270,126.0000 | Mar 10, 2026 |
| December 2025 | 11,535,577.0000 | Mar 10, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 11,535,577.0000 | -5,507,592.0000 | -2,853,274.0000 | 29,086,945.0000 | 26,014,118.0000 | Mar 10, 2026 |
| December 2024 | 8,270,126.0000 | -3,302,999.0000 | -2,765,797.0000 | 23,925,679.0000 | 16,324,405.0000 | Mar 10, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
40/100
Profitability0
Growth89
Balance sheet11
Cash generation1
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $11.54M | Jan 1, 2025 – Dec 31, 2025 | Mar 10, 2026 | 10-K |
| Previous period revenueRevenues | $8.27M | Jan 1, 2024 – Dec 31, 2024 | Mar 10, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$5.51M | Jan 1, 2025 – Dec 31, 2025 | Mar 10, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivitiesContinuingOperations | -$2.85M | Jan 1, 2025 – Dec 31, 2025 | Mar 10, 2026 | 10-K |
| Total assetsAssets | $29.09M | Dec 31, 2025 | Mar 10, 2026 | 10-K |
| Total liabilitiesLiabilities | $26.01M | Dec 31, 2025 | Mar 10, 2026 | 10-K |